Olaparib (AZD2281) is a potent, orally active PARP1/2 inhibitor (IC50 = 5 and 1 nM, respectively) and an autophagy activator. It enhances cancer cell death by blocking BER and is effective alone or in combination with alkylating agents. Reagent-grade; for laboratory research purposes only.
Usually ships within 24 hours.